Get started
Diamyd Medical AB Class BDiamyd Medical AB Class BDiamyd Medical AB Class B

Diamyd Medical AB Class B

No trades
See on Supercharts
Overview
Financials News Discussions Technicals Seasonals

DMN chart


Full chart

Key stats


Market capitalization
‪136.10 M‬ EUR
Dividend yield (indicated)
—
Price to earnings Ratio (TTM)
—
Basic EPS (TTM)
−0.15 EUR
Net income (FY)
‪−13.32 M‬ EUR
Revenue (FY)
‪11.40 K‬ EUR
Shares float
‪113.72 M‬
Beta (1Y)
0.79

Employees


Employees (FY)
28
Change (1Y)
+3 +12.00%
Revenue / Employee (1Y)
407.27 EUR
Net income / Employee (1Y)
‪−475.72 K‬ EUR

About Diamyd Medical AB Class B


Sector
Health Technology
Industry
Pharmaceuticals: Major
CEO
Ulf Hannelius
Website
diamyd.com
Headquarters
Stockholm
Founded
1984
ISIN
SE0005162880
FIGI
BBG00XV7PGY7
Diamyd Medical AB engages in the development of pharmaceutical products for the treatment of diabetes and other serious inflammatory diseases. Its pipeline includes Diamyd and Remygen, which targets the underlying causes of diabetes, dysfunction, and loss of the pancreatic beta cells. The company also develops and invests in stem cell and medical technology. Diamyd Medical was founded by Anders Essen-Moller in 1996 and is headquartered in Stockholm, Sweden.

Check out other big names from the same industry as DMN.

Financials


Performance
Revenue to profit conversion
Debt level and coverage
Earnings
Next:—

DMN news



Technicals


Summarizing what the indicators are suggesting.
Oscillators
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Oscillators
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Summary
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Summary
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Summary
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Moving Averages
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Moving Averages
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy

Seasonals


Displays a symbol's price movements over previous years to identify recurring trends.

Frequently Asked Questions


The current price of DMN is 0.99 EUR — it hasn't changed in the past 24 hours. Watch Diamyd Medical AB Class B stock price performance more closely on the chart.
Depending on the exchange, the stock ticker may vary. For instance, on GETTEX exchange Diamyd Medical AB Class B stocks are traded under the ticker DMN.
DMN stock has fallen by −2.33% compared to the previous week, the month change is a 2.14% rise, over the last year Diamyd Medical AB Class B has showed a −18.44% decrease.
DMN reached its all-time high on Mar 3, 2021 with the price of 3.91 EUR, and its all-time low was 0.55 EUR and was reached on Oct 25, 2023. View more price dynamics on DMN chart.
See other stocks reaching their highest and lowest prices.
DMN stock is 6.13% volatile and has beta coefficient of 0.79. Track Diamyd Medical AB Class B stock price on the chart and check out the list of the most volatile stocks — is Diamyd Medical AB Class B there?
Today Diamyd Medical AB Class B has the market capitalization of ‪136.11 M‬, it has decreased by −7.08% over the last week.
Yes, you can track Diamyd Medical AB Class B financials in yearly and quarterly reports right on TradingView.
DMN net income for the last quarter is ‪−4.01 M‬ EUR, while the quarter before that showed ‪−4.00 M‬ EUR of net income which accounts for −0.35% change. Track more Diamyd Medical AB Class B financial stats to get the full picture.
No, DMN doesn't pay any dividends to its shareholders. But don't worry, we've prepared a list of high-dividend stocks for you.
As of Sep 18, 2025, the company has 28 employees. See our rating of the largest employees — is Diamyd Medical AB Class B on this list?
EBITDA measures a company's operating performance, its growth signifies an improvement in the efficiency of a company. Diamyd Medical AB Class B EBITDA is ‪−16.53 M‬ EUR, and current EBITDA margin is ‪−111.42 K‬%. See more stats in Diamyd Medical AB Class B financial statements.
Like other stocks, DMN shares are traded on stock exchanges, e.g. Nasdaq, Nyse, Euronext, and the easiest way to buy them is through an online stock broker. To do this, you need to open an account and follow a broker's procedures, then start trading. You can trade Diamyd Medical AB Class B stock right from TradingView charts — choose your broker and connect to your account.
Investing in stocks requires a comprehensive research: you should carefully study all the available data, e.g. company's financials, related news, and its technical analysis. So Diamyd Medical AB Class B technincal analysis shows the sell today, and its 1 week rating is sell. Since market conditions are prone to changes, it's worth looking a bit further into the future — according to the 1 month rating Diamyd Medical AB Class B stock shows the sell signal. See more of Diamyd Medical AB Class B technicals for a more comprehensive analysis.
If you're still not sure, try looking for inspiration in our curated watchlists.